Common Stock Warrants

DiaMedica Therapeutics Announces 2018 Financial Results and Provides Corporate Update – Nasdaq

DiaMedica Therapeutics Announces 2018 Financial Results and Provides Corporate Update Nasdaq Dosed first patients in Phase Ib study of DM199 in Chronic Kidney Disease patients under an IND accepted by the FDA in 2018; Plan to initiate Phase. … Continue reading

DiaMedica Therapeutics Announces 2018 Financial Results and Provides Corporate Update – Nasdaq Read More »

Avicanna announces filing of amended & restated preliminary prospectus – Canada NewsWire

Avicanna announces filing of amended & restated preliminary prospectus Canada NewsWire NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH … … Continue reading

Avicanna announces filing of amended & restated preliminary prospectus – Canada NewsWire Read More »

Sigma Labs, Inc. (SGLB) EPS Estimated At $-0.14 | Thorold News – Thorold News

Sigma Labs, Inc. (SGLB) EPS Estimated At $-0.14 | Thorold News Thorold News Analysts expect Sigma Labs, Inc. (NASDAQ:SGLB) to report $-0.14 EPS on April, 5.They anticipate $0.20 EPS change or 58.82 % from last quarter’s $-0.34 EPS. … Continue reading

Sigma Labs, Inc. (SGLB) EPS Estimated At $-0.14 | Thorold News – Thorold News Read More »

Truett-hurst Inc (NASDAQ:THST) Stock Price Up as Sentiment Improves, now at 1.5 – The EN Bulletin

Truett-hurst Inc (NASDAQ:THST) Stock Price Up as Sentiment Improves, now at 1.5 The EN Bulletin In Q4 2018 Truett-hurst Inc (NASDAQ:THST) big money sentiment increased to 1.5, according to SEC.gov filings. So its up 0.50, from 2018Q3’s 1. 3 investment … … Continue reading

Truett-hurst Inc (NASDAQ:THST) Stock Price Up as Sentiment Improves, now at 1.5 – The EN Bulletin Read More »

Cotinga Pharmacueticals Provides Scientific and Business Update at Annual General Meeting and Announces Unit Offering – Nasdaq

Cotinga Pharmacueticals Provides Scientific and Business Update at Annual General Meeting and Announces Unit Offering Nasdaq TORONTO and BOSTON, March 19, 2019– Cotinga Pharmaceuticals Inc., a clinical stage biopharmaceutical company advancing a pipeline of targeted. … Continue reading

Cotinga Pharmacueticals Provides Scientific and Business Update at Annual General Meeting and Announces Unit Offering – Nasdaq Read More »

Aleafia Health Commences Trading on the Toronto Stock Exchange – GlobeNewswire

Aleafia Health Commences Trading on the Toronto Stock Exchange GlobeNewswire TORONTO, March 19, 2019 (GLOBE NEWSWIRE) — Aleafia Health Inc. (TSX: ALEF, OTC: ALEAF, FRA: ARAH) (“Aleafia Health” or the “Company”) is pleased to … … Continue reading

Aleafia Health Commences Trading on the Toronto Stock Exchange – GlobeNewswire Read More »

Why the FDA Commissioner Pushed to Shorten Medical Device Approval Process – Benzinga

Why the FDA Commissioner Pushed to Shorten Medical Device Approval Process Benzinga PALM BEACH, Florida, March 19, 2019 /PRNewswire/ — We all know the FDA is the arm of the U.S. government that, among other things, controls and oversees … … Continue reading

Why the FDA Commissioner Pushed to Shorten Medical Device Approval Process – Benzinga Read More »

StillCanna (CSE: STIL) Signs Definitive Agreement for the Acquisition of a Leading European #Hemp Cultivator Olimax – InvestorIdeas.com

StillCanna (CSE: STIL) Signs Definitive Agreement for the Acquisition of a Leading European #Hemp Cultivator Olimax InvestorIdeas.com Vancouver, British Columbia – March 19, 2019 (Newsfile Corp.) (Investorideas.com Newswire) StillCanna Inc. (CSE: STIL) (“StillCanna” or the “Company”) is … … Continue reading

StillCanna (CSE: STIL) Signs Definitive Agreement for the Acquisition of a Leading European #Hemp Cultivator Olimax – InvestorIdeas.com Read More »